Stonehage Fleming Financial Services’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,429
Closed -$13K 236
2017
Q4
$13K Sell
3,429
-3,429
-50% -$14.7K ﹤0.01% 223
2017
Q3
$22K Buy
6,858
+3,429
+100% +$12.9K ﹤0.01% 233
2017
Q2
$15K Hold
3,429
﹤0.01% 234
2017
Q1
$16K Hold
3,429
﹤0.01% 268
2016
Q4
$7K Hold
3,429
﹤0.01% 282
2016
Q3
$10K Hold
3,429
﹤0.01% 300
2016
Q2
$9K Hold
3,429
﹤0.01% 277
2016
Q1
$10K Hold
3,429
﹤0.01% 284
2015
Q4
$28K Hold
3,429
﹤0.01% 111
2015
Q3
$24K Hold
3,429
﹤0.01% 125
2015
Q2
$31K Hold
3,429
﹤0.01% 125
2015
Q1
$32K Hold
3,429
﹤0.01% 138
2014
Q4
$33K Buy
+3,429
New +$34.5K ﹤0.01% 150

Other funds holding CDMO

Stonehage Fleming Financial Services's CDMO Position: Q1 2018 in Review

Stonehage Fleming Financial Services sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2018, closing a stake of 3,429 shares — an estimated $13K sold.

Stonehage Fleming Financial Services first reported a position in CDMO in Q4 2014 and held it in 13 quarters. The position peaked at $33K in Q4 2014. 70 funds tracked by Wall St. Rank hold CDMO as of Q1 2018.

  • Stonehage Fleming Financial Services reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 3,429 Avid Bioservices, Inc. Common Stock shares in Q1 2018, an estimated $13K.
  • Stonehage Fleming Financial Services first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2014 and held it in 13 quarters.
  • Stonehage Fleming Financial Services's Avid Bioservices, Inc. Common Stock position peaked at $33K in Q4 2014.
  • 70 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2018.

Based on Stonehage Fleming Financial Services's 13F filing for Q1 2018, filed 11 Oct 2019.